Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05819827 · ClinicalTrials.gov registry record
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 13
- Enrollment target
NCT05819827: Clinical Trial study, sponsored by Mayo Clinic.
NCT05819827 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05819827 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The objective of this pilot cohort study is to investigate associations between CIN and changes in gut microbiome composition profiles.
Interventions
- OTHER Blood and Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-04-19 |
| Est. Completion | 2024-05-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05819827
The ClinicalTrials.gov registry entry for NCT05819827 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood and Tissue is the first listed.
NCT05819827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05819827 about?
NCT05819827 is a clinical study titled "Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics". The objective of this pilot cohort study is to investigate associations between CIN and changes in gut microbiome composition profiles.
What is the current status of trial NCT05819827?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2023-04-19. Estimated completion is 2024-05-21.
What interventions are being tested in trial NCT05819827?
The interventions under investigation include: Blood and Tissue (OTHER).
Who is sponsoring clinical trial NCT05819827?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.